Physician profile
Benjamin Thomas Pagano
NPI 1669722732
$4,284.46
in general payments reported to CMS, 2019-2025
41 companies · $1,481 in 2025
The $1,481 reported for 2025 was more than what 93% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $648 · 2022: $754 · 2023: $701 · 2024: $701 · 2025: $1,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,831 · Education: $51.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,830.86 |
| Education | $51.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $542.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Beta Bionics, INC. | $386.80 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Lilly USA, LLC | $318.38 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $311.06 | 2021-2025 | Tepezza, Evenity, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.04 | 2021-2025 | Jardiance |
| Corcept Therapeutics | $245.62 | 2023-2025 | Korlym |
| Abbvie INC. | $203.17 | 2021-2025 | |
| Clarus Therapeutics INC. | $187.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.64 | 2022-2024 | |
| Radius Health, INC. | $137.13 | 2021-2024 | Tymlos |
| Sequel Med Tech, LLC | $133.87 | 2025 | Twiist |
| Dexcom, INC. | $129.41 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $124.18 | 2021-2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $107.38 | 2021-2025 | |
| Mannkind Corporation | $102.11 | 2021-2024 | Afrezza |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $99.92 | 2021-2025 | Intellis Adaptivestim, Minimed 780g |
| Insulet Corporation | $88.39 | 2021-2025 | Omnipod |
| Astrazeneca Pharmaceuticals Lp | $73.11 | 2022-2025 | Farxiga, Lokelma |
| Abbott Laboratories | $67.60 | 2022-2024 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $65.71 | 2025 | Isturisa |
| Amarin Pharma, INC. | $62.29 | 2021-2023 | |
| Tandem Diabetes Care, INC. | $52.80 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Intuity Medical INC | $49.13 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Alvogen INC | $39.05 | 2025 | Teriparatide |
| Antares Pharma, INC. | $36.86 | 2024 | Xyosted |
| Zealand Pharma US, INC. | $35.73 | 2021 | |
| Ascensia Diabetes Care US INC. | $24.02 | 2025 | |
| Glaxosmithkline, LLC. | $23.45 | 2025 | Arexvy, Shingrix |
| Ibsa Pharma INC. | $23.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.93 | 2023 | |
| Halozyme INC | $19.55 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $19.10 | 2025 | |
| Cequr Corporation | $18.61 | 2023 | Cequr Simplicity |
| Ascendis Pharma Endocrinology INC | $17.28 | 2025 | Yorvipath |
| Acella Pharmaceuticals, LLC | $16.46 | 2025 | NP Thyroid 60 |
| Tolmar, INC. | $15.76 | 2023 | |
| Chiesi USA, INC. | $15.49 | 2024 | Mycapssa |
| Alexion Pharmaceuticals, INC. | $14.90 | 2024 | |
| Lifescan, INC. | $14.56 | 2023 | |
| Astellas Pharma US INC | $14.43 | 2024 | Veozah |
| Pfizer INC. | $13.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Pagano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.